18 results
10-K
2022 FY
OBSVF
ObsEva SA
31 Mar 23
Annual report
4:01pm
sufficient quantities of our products candidates or receive raw materials in a timely manner, we could be required to delay our ongoing clinical trials … for the foreseeable future. There are a limited number of suppliers for raw materials that we use to manufacture our drugs and there may be a need to assess
6-K
EX-99.1
wxcvkzsmdu9 a2gltd
7 Aug 19
Current report (foreign)
7:21am
20-F
nepsdq8ek2
21 Apr 17
Annual report (foreign)
12:00am
F-1
EX-10.2
6tr 1f6dp
30 Dec 16
Registration statement (foreign)
12:00am
F-1
EX-10.1
wwln25hx
30 Dec 16
Registration statement (foreign)
12:00am
F-1
bnqw 1mr5o5
30 Dec 16
Registration statement (foreign)
12:00am
DRS
EX-10
myot0zo
14 Oct 16
Draft registration statement
12:00am
DRS
EX-10
5xt 8ubzcvxwb
14 Oct 16
Draft registration statement
12:00am
DRS
csk9i
14 Oct 16
Draft registration statement
12:00am
- Prev
- 1
- Next